AMW

AMW GmbH is a specialty pharmaceutical company focused on biodegradable implants, providing patients and partners access to long-acting, value-added medicines for improved adherence and cost-effective therapy. The company covers the entire value chain from co-development to manufacturing and international commercialization, with two approved medical products — implants releasing goserelin and leuprorelin — distributed worldwide through direct sales and local and global pharma partners.